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Abstract
Repetitive transcranial magnetic stimulation (rTMS) is a widely-used method for modulating cortical excitability in humans,
by mechanisms thought to involve use-dependent synaptic plasticity. For example, when low frequency rTMS (LF rTMS) is
applied over the motor cortex, in humans, it predictably leads to a suppression of the motor evoked potential (MEP),
presumably reflecting long-term depression (LTD) – like mechanisms. Yet how closely such rTMS effects actually match LTD
is unknown. We therefore sought to (1) reproduce cortico-spinal depression by LF rTMS in rats, (2) establish a reliable animal
model for rTMS effects that may enable mechanistic studies, and (3) test whether LTD-like properties are evident in the rat
LF rTMS setup. Lateralized MEPs were obtained from anesthetized Long-Evans rats. To test frequency-dependence of LF
rTMS, rats underwent rTMS at one of three frequencies, 0.25, 0.5, or 1 Hz. We next tested the dependence of rTMS effects on
N-methyl-D-aspartate glutamate receptor (NMDAR), by application of two NMDAR antagonists. We find that 1 Hz rTMS
preferentially depresses unilateral MEP in rats, and that this LTD-like effect is blocked by NMDAR antagonists. These are the
first electrophysiological data showing depression of cortical excitability following LF rTMS in rats, and the first to
demonstrate dependence of this form of cortical plasticity on the NMDAR. We also note that our report is the first to show
that the capacity for LTD-type cortical suppression by rTMS is present under barbiturate anesthesia, suggesting that future
neuromodulatory rTMS applications under anesthesia may be considered.
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Introduction
Transcranial magnetic stimulation (TMS) is a well-tolerated
method for noninvasive stimulation and modulation of regional
cortical excitability in humans. TMS is based on the principles of
electromagnetic induction where small intracranial electrical
currents are induced by a powerful fluctuating extracranial
magnetic field. In common clinical and experimental practice,
TMS is applied unilaterally over the motor cortex, and coupled
with surface electromyography (EMG) such that reliable unilateral
motor evoked potentials (MEP) can be recorded from the subject’s
contralateral hand muscles. MEP measures can then be used as
markers of cortico-spinal excitability [1,2].
Repetitive transcranial magnetic stimulation (rTMS) of the
human motor cortex induces a durable change in cortico-spinal
excitability as reflected by a lasting change in the MEP size and
appears mediated, at least in part, by intracortical mechanisms
[3,4]. Such capacity to modulate cortical excitability is thought to
critically contribute to the therapeutic effects of rTMS in several
neuropsychiatric diseases, including major depression, chronic
pain and epilepsy [5–10].
The mechanisms by which rTMS alters cortico-motor excit-
ability are not sufficiently understood. Human data and experi-
mental work in animals suggest that the lasting effects of high ($
10 Hz) or low (#1 Hz) rTMS on cortico-spinal excitability rely on
synaptic plasticity mechanisms similar to those of long-term-
potentiation (LTP) and long-term depression (LTD) [11–18].
Specifically, rTMS resembles classical LTD and LTP plasticity in
that rTMS effects are frequency dependent, cause an immediate
change in excitability, outlast stimulation, and appear to be
dependent on activation of the N-methyl-D-aspartate glutamate
receptor (NMDAR) [3].
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research, our group has developed methods for lateralized single
pulse TMS (spTMS) and paired-pulse TMS (ppTMS) to enable
focal cortical stimulation and provide a measure of regional
cortical excitability [19–22]. Here, we establish an rTMS model
that will enable mechanistic studies of LF rTMS protocols that are
currently used in the clinical arena [23,24] and anticipate this as a
step toward valuable insights at the cellular and molecular level
that can be obtained from animal models to improve therapeutic
clinical LF rTMS protocols. Specifically, we demonstrate that a
lasting reduction in motor excitability can be induced by LF rTMS
in anesthetized rats, and examine whether and to what extent the
rTMS-induced change in excitability depend on stimulation
frequency and the NMDAR.
Methods
Ethics Statement
All animal procedures were in accordance with the guidelines of
the National Institutes of Health’s Guide for the Care and Use of
Laboratory Animals. The protocol was approved by the Animal Care
and Use Committee at Boston Children’s Hospital (protocol
number: 10-03-1633R).
Animals
48 adult male Long-Evans rats (231 g 620.7 g) were used. All
efforts were made to minimize the number of rats used in the
present experiments.
Anesthesia
Animals were anesthetized with intraperitoneal (i.p.) sodium
pentobarbital at 65 mg/kg (50 mg/ml solution). Ten minutes later
a second dose, equal to approximately 20% of the primary
injection, was given i.p. This pentobarbital dosing protocol was
adapted from previously described methods and enabled sufficient
anesthesia for the 70-minute experiment [19,20]. Once anesthe-
tized, rats were placed into a stereotaxic frame (Stoelting Wood
Dale, Illinois). The frame was electrically grounded. The
stereotaxic frame’s points of contact with the animal (ear bars
and nose clamp) were covered with several layers of paraffin film
to avoid potential conductance of induced electrical current
between the rat and the metal frame, and the rat torso was isolated
from the frame base by plastic padding [19].
Pharmacology
Two separate groups, both stimulated with 1 Hz rTMS, (n=6
rats/group) received MK801 3 mg/kg (2 mg/ml) or AP5 5 mg/kg
(5 mg/ml) dissolved in 0.9% saline by i.p. injection. These doses
were based on published methods for systemic administration of
the NMDAR antagonists AP5 [25–29] and MK801 [30–33].
NMDAR antagonists were administered 20 minutes before
sodium pentobarbital. Note: due to the sedating effects of
MK801, the second dose of pentobarbital was not administered
in this group.
Electromyography
MEPs were recorded with monopolar uninsulated 28 G
stainless steel needle electrodes (Chalgren Enterprises Inc., Gilroy,
CA) inserted into each brachioradialis muscle (Fig. 1a) [19,20].
Brachioradialis location was determined by palpation of the
extended forelimb. A reference electrode was positioned distally in
the paw between the 3rd and 4th digit. Each animal was
electrically grounded by one needle electrode placed in the tail
(Fig. 1a). EMG signal was band pass filtered 100–1000 Hz,
amplified X1000 (AM Systems Model 1700; Sequim, WA),
digitized with 40 kHz sampling, and stored for post hoc analysis
(AD Instruments Colorado Springs, CO).
Figure 1. (A) EMG-rTMS rat setup. Photograph shows rat in stereotaxic frame. Monopolar stainless steel needle electrodes are placed into the
brachioradialis of each forelimb and between the third and fourth digit in the footpad (arrows). A ground electrode is inserted in the tail. A 40 mm
figure-of-eight coil is fixed to a micromanipulator arm and positioned over the left or right hemisphere. (B) Demonstration of contralateral
activation by TMS in rat. Representative brachioradialis MEPs (average of ten consecutive sweeps) are shown. Note, at motor threshold, lateralized
TMS elicits isolated MEP in the contralateral forelimb.
doi:10.1371/journal.pone.0091065.g001
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A MagStim Rapid stimulator and a customized 70 mm figure-
of-eight coil (40 mm external diameter of each lobe; Magstim
Company, Wales, U.K.) were used to apply rTMS over the motor
cortex (coil center 9.060.9 mm lateral and 3.361.0 mm anterior
to bregma). The coil position was adjusted to produce unilateral
MEPs in the brachioradialis muscle contralateral to the site of
stimulation and no MEPs in the ipsilateral brachioradialis at motor
threshold (MT) (Fig. 1b). By visual inspection, such lateralized
TMS produced a twitch only in the contralateral forepaw and
shoulder. An exclusive unilateral MEP response was the inclusion
criterion for the study.
TMS intensity was recorded as percent machine output (%
MO), with 100% corresponding to the maximal electrical current
in the coil with corresponding maximal magnetic field. Bregma
was located by measurement of the interaural line [34]. MT was
defined as the minimum stimulus intensity to obtain MEPs of $
20 mV peak-to-peak amplitude in at least 5 of 10 trials [20].
To stay within a relatively narrow steady-state anesthesia time
window, a pre-rTMS recruitment curve, similar to our previous
publication, was rapidly generated by adjusting the stimulator
intensity in steps of 5% MO from 55% to 95% MO with a 7 sec
inter-stimulus interval for a total of 630 seconds [19]. 10 stimuli
were repeated at each step in the recruitment curve. Following
baseline and MT acquisition, the stimulator was set to either 100%
MT for active stimulation or 5% MO for sham stimulation (n=6
rats per treatment condition). Stimulation was performed at one of
three frequencies; 1 Hz, 0.5 Hz, or 0.25 Hz such that total
number of pulses delivered was 300, resulting in 5, 10, and 20
minutes of stimulation for 1, 0.5, and 0.25 Hz, respectively.
For the purposes of timing, we designated end of rTMS as
minute ‘‘0’’. Thereafter, two additional recruitment curves were
obtained at 8 and 35 minutes following rTMS (Fig. 2a). The time
to the first post-rTMS recruitment curve was limited by the
stimulator and coil temperature as pilot runs indicated that a 7-
minute cooling period was required for the coil to be functional
after 300 rTMS pulses. Therefore, the 8-minute time point was
selected as the earliest start point for the recruitment curve used to
assess immediate rTMS effects. The second post-rTMS recruit-
ment curve was started 15 minutes after the end of the first post-
stimulation curve (lasting 12 minutes), making it the 35
th minute of
the experiment.
Statistical Analysis
Absolute integrated voltage from ten consecutive sweeps was
averaged for comparison of MEP voltages at each TMS intensity
[19,20]. Means of derived MEP amplitudes were analyzed at each
timepoint after LF rTMS as a ratio relative to matched MO from
the baseline recruitment curve for each animal. All data expressed
as ratios were log-transformed prior to analysis. Group and
stimulation intensity contributions to differences between recruit-
ment curves were evaluated by two-way ANOVA with corre-
sponding post hoc paired t-test.
For purposes of analysis, comparisons between multiple groups
were made using integrated MEP voltage ratios and their log
transformation at 80% MO, an intensity that was the lowest MO
value that was suprathreshold for MEP activation in all test
animals. We note also that we chose the 80% MO intensity,
somewhat arbitrarily, given the relatively coarse MT approxima-
tion in 5% MO steps, and absent EMG-based definition of MT in
rats.
Results
MEP Suppression by LF rTMS
Following 1 Hz rTMS (LF rTMS), the integrated MEP voltage
is reduced at all suprathreshold TMS intensities for the duration of
the experiment, up to 47 minutes post-rTMS (Fig. 2a). Represen-
tative traces demonstrate the reduction seen in MEP amplitude for
active 1 Hz stimulation as compared to its sham counterpart
(Fig. 2c). Two-way ANOVA comparison of the integrated MEP
voltages between groups indicates that recruitment curve is
significantly depressed at both the 8-minutes [stimulation effect:
F(1,90)=28.35, p,0.0001] and 35-minutes [stimulation effect:
F(1,90)=30.29, p,0.0001] timepoints following the 300-pulse
rTMS train (Fig. 2b). Post hoc t-tests show that the difference is
largely attributable to significant suppression at the 8-minutes
timepoint for 75, 80, 85 and 90% MO (p,0.01, p,0.001, p,
0.01, p,0.05, respectively) when comparing baseline and post-
stimulation absolute integrated MEP voltages. For the 35-minutes
timepoint, we note a significant decrease in values relative to sham
at 75, 80 and 85% MO (p,0.05, p,0.01, p,0.01).
rTMS Effect is Frequency-dependent
We also find that the suppressive LF rTMS effect is strongly
dependent on the rTMS frequency. Specifically, there is no
significant difference between sham and active stimulation for
either 0.25 Hz or 0.5 Hz at either timepoint after the LF rTMS
train. This is illustrated in figure 3 which shows a comparison of
the effects of rTMS trains over a short range of frequencies at 80%
MO. In contrast, after 1 Hz active rTMS the MEPs are
significantly suppressed to 55% (618%; p,0.004) and 69%
(627%; p,0.04) of the baseline integrated voltage, at the 8-
minutes and 35-minutes timepoints, respectively. The time effect
not significant for either group, but the frequency effect of
frequency was significant for both sham [F(2,30)=4.43, p,0.021]
and active [F(2,30)=6.20, p,0.0056] by two-way ANOVA.
Furthermore, two-way ANOVA analysis of frequency versus
stimulation condition at both 8 minute and 35 minutes identified
significant contributions of both time points respectively [frequen-
cy effect: F(2,30)=4.88, p,0.015; sham/active effect:
F(1,30)=7.95, p,0.0084] [frequency effect: F(2,30)=4.31, p,
0.023; sham/active effect: F(1,30)=4.33, p,0.046].
1 Hz rTMS Effect is Dependent on NMDAR Activation
To test whether MEP modulation by LF rTMS is dependent on
NMDAR activation, we treated separate groups of rats (n=6 rats
per group) with either the non-competitive NMDA antagonist
MK801 or the competitive antagonist AP5. Motor threshold (MT)
was unchanged following either MK801 or AP5 administration.
MT comparison among treatment conditions showed no signifi-
cant difference among groups when evaluated by one-way
ANOVA (Fig. 4a). Average MT across all groups was
73.562.5% MO. Following active rTMS, at 80% MO, we find
48.2% (p,0.01) and 53% (p,0.05) reduction of the MEP
integrated voltage at 8 and 35-minutes after the rTMS train,
respectively, when compared to their individual pre-rTMS
baseline. However, there is no significant difference between
sham, MK801, and AP5 conditions (Fig. 4b).
Discussion
LTD-like Forelimb MEP Suppression in Anesthetized Rats
As a step toward establishing a mechanistic rTMS model and
enabling further trasnslational rTMS research, we show for the
first time a long-term depression of the lateralized forelimb MEPs
Low Frequency rTMS Reduces Rat Cortex Excitability
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spinal excitability after rTMS has several essential features of
LTD-type plasticity: (1) Frequency dependence with preferential
response to 1 Hz stimulation, (2) immediate (within 8 minutes) and
durable (up to 35 minutes) modulation of post-stimulation
excitability, and (3) NMDAR dependence. Notably, the magni-
tude and duration of MEP suppression by LF rTMS in our study
approximates the 20–50% MEP reduction reported in humans
15–30 minutes after 1 Hz rTMS [13,35,36]. We also demonstrate
that other aspects of forelimb MEP modulation by LF rTMS are
in line with human studies, including frequency dependence and
NMDAR involvement. We appreciate that other research groups
have also produced analogous results in different experimental
rTMS settings [37–39], and underscore that the present report
adds to the literature results specific to plasticity of a lateralized
motor evoked response, akin to that which is seen in humans [19].
Frequency Dependent Effect of LF rTMS
1 Hz rTMS elicits a greater reduction in motor excitability than
either 0.5 Hz or 0.25 Hz stimulation. This is consistent with
published LTD data suggesting a preferential response to 1.0 Hz
stimulation when compared to other low frequencies [40]. These
results also approximate frequency-dependent effects seen in low-
frequency rTMS in humans, whereby 1.0 Hz stimulation has the
most prominent effect on MEP size [35,41]. While sub-1.0 Hz
stimulation appears to have little to no effect on the MEP in our
setup, a depression of the MEP by lower frequencies has been
shown in humans [42] and LF rTMS below 1.0 Hz has
Figure 2. (A) Representative recruitment curves. Averaged integrated voltage (uV*s) for the baseline recruitment acquisition from all animals is
compared to post-stimulation values at both the 8 and 35-minutes timepoints after rTMS. By 2-way ANOVA, there is a significant reduction in the
integrated MEP size following 1 Hz stimulation at both 8-minutes [stimulation effect: F(1,162)=294.3, p,0.0001; MO effect: F(8,162)=127.5, p,
0.0001; interaction effect: F(8,162)=25.86, p,0.0001] and the 35-minutes [stimulation effect: F(1,162)=355.6, p,0.0001; MO effect: F(8,162)=118.2,
p,0.0001; interaction effect: F(8,162)=27.23, p,0.0001] timepoints. Significance is confirmed by post-hoc t-test from 75–95% MO. Error bars indicate
SD. ***p,0.001. (B) MEP changes following 1 Hz rTMS. All values are normalized to sham rTMS control. The difference between active and sham
rTMS recruitment curves is significant by 2-way ANOVA at the 8-minute [stimulation effect: F(1,90)=28.35, p,0.0001] and 35-minutes [stimulation
effect: F(1,90)=30.29, p,0.0001] timepoints. At individual stimulator intensities, using post-hoc t-test, there is a significant suppression at 75, 80, 85
and 90% MO (p,0.01, p,0.001, p,0.01, p,0.05, respectively) at the 8-minutes timepoint, and significant suppression at 75, 80 and 85% MO (p,
0.05, p,0.01, p,0.01) at the 35-minutes timepoint. Error bars indicate SD. *p,0.05; **p,0.01; ***p,0.001. (C) Representative MEPs following
1 Hz active or sham rTMS. Ten consecutive MEP sweeps at 55% MO, 100% MT, and 95% MO from one animal per condition, active or sham rTMS,
are shown. Baseline traces are followed by MEPs generated at the same MO at the 8-minutes and 35-minutes timepoints.
doi:10.1371/journal.pone.0091065.g002
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tinnitus (0.5 Hz [44]), among other disease states [45,46].
Plausibly, this discrepancy is due to the physiologic differences
between our rat setup and human rTMS, or to the the physiologic
effects of anesthesia, or to the relatively short train duration (300
pulses) which is 3–6 times shorter than many human rTMS
protocols (reviewed in [42]). Yet an additional and intriguing
explanation is perhaps a fundamental difference in physiologic
sequelae of 1 Hz rTMS as compared to lower frequencies as
suggested in limited human work [41]. Further examination of
rodent LF rTMS, particularly if coupled with molecular neuro-
science techniques that are available only in preclincal studies,
could provide valuable insight into the mechanism of action these
sub-1.0 Hz frequencies in neurological disorders. Although
detailed study of a large range of stimulation protocols as has
been done in humans (reviewed in [42]) is beyond the scope of this
experiment, our anticipation is that the present report will
facilitate such mechanistic studies with methods for lateralized
rTMS in anesthetized rats [19].
NMDA Dependent Mechanism of Neuronal Modulation
by rTMS
Our data provide further insight into LF rTMS mechanism by
testing the hypothesis that LF rTMS mediated motor suppression
is dependent on NMDAR activation. In human studies, the role of
NMDARs in high frequency (potentiating) rTMS has been studied
extensively [47,48]. However, human studies of the NMDAR
contribution to motor cortex plasticity with LF rTMS are limited
in number, and also limited to only one noncompetitive NMDA
antagonist, dextromethorphan, which likely acts on the NMDAR
indirectly via active metabolites and may have off-target effects
[48,49]. Similar future human rTMS work with healthy volunteers
will also, for ethical reasons, be very likely limited to sub-anesthetic
doses of NMDAR antgonists such as ketamine or synthetic
opioids. Thus the rat model here provides an explicit validation for
the LF rTMS mechanism, as we demonstrate a similar NMDAR
dependence in rats as is suggested in human studies, but with more
selective NMDAR competitive and noncompetitive NMDAR
antagonism.
Figure 3. MEP change as a function of rTMS frequency. All conditions are shown at 80% MO. All ratios of average MEP integrated voltage
relative to pre-rTMS baseline were log transformed. Compared to its baseline, 1 Hz active rTMS is the only condition where the MEP size was
suppressed at both the 8-minues (p,0.01) and 35-minutes (p,0.05) timepoints. Error bars indicate SD. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0091065.g003
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AP5, and found that application of either antagonist prevents
MEP depression by 1 Hz rTMS. Notably, in classic in vitro LTD
experimental setups, in isolated hippocampal slices, AP5 has been
shown to inhibit LTD [50–52], but MK801 has not [53,54]. Thus
we find a small discrepancy between the pharmacology of the
1 Hz focal electrical stimulation in vitro and 1 Hz rTMS in vivo.
We underscore this discrepancy as such distinctions in the
biochemistry of rTMS effects and those of classic LTD data will
need to be reconciled if we are to apply information from the vast
LTD literature toward experimental design and clinical rTMS
protocols. It is ultimately not surprising that rTMS effects, which
could follow from simultaneous electromagnetic stimulation of all
components of a cortical volume (principal neurons, interneurons,
etc.), may not be fully predicted by data from experimental
protocols that involve precise electrical stimulation of a single
afferent pathway and focal recording from its target; for instance,
where the Schaffer collaterals are stimulated to evoke a post-
synaptic response in CA1 in classic LTD experimental setups.
rTMS in an Anesthetized Subject
Our data are the first to show LTD-type MEP suppression by
1 Hz rTMS in rats under pentobarbital anesthesia. For extension
of the present experiment toward further studies, the finding of
motor pathway plasticity under anesthesia is valuable, as
anesthesia will likely be needed for future rodent rTMS
Figure 4. (A) Average motor threshold per treatment group. Percent machine output needed to achieve motor thresholds across sham 1 Hz
rTMS, 1 Hz rTMS, MK801, and AP5 (74.2%MO 67.3%MO, 75.8%MO 64.9%MO, 74.2%MO 63.8%MO, 70%MO 64.5%MO respectively). No significant
difference between groups was detected. Error bars indicate SD. (B) Effects of NMDAR antagonists on MEP suppression by 1 Hz rTMS.
Integrated MEP voltage (uV*s) is measured at 80% MO. Statistics per treatment pair were obtained by comparison with the corresponding sham
condition. For the 1 Hz rTMS group, there is a 48.2% (p,0.01) and 53% (p,0.05) reduction at the 8-minutes and 35-minutes timepoints after rTMS,
respectively. There is no significant change from pre-rTMS baseline after pretreatment with MK801 or AP5 conditions. Error bars indicate SD.*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0091065.g004
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will require further exploration [20,55].
An interesting translational extension of the data may be toward
testing whether rTMS-mediated cortical plasticity is preserved in
humans who are under barbiturate sedation or another anesthetic
state. Such scenarios may be of clinical relevance for patient
populations, such as children or adults with developmental
disabilities, who may benefit from rTMS, but who may not
tolerate rTMS in the awake state. Our results demonstrating that
cortical excitability can be modulated by rTMS in the anesthetized
state also raise the prospect for rTMS in patients treated with high
barbiturate doses for management of an acute medical condition
such as status epilepticus, as supported by recent case reports
[56,57].
Study Limitations
We note limitations to the present study that warrant further
investigation. Among these, is the confound of anesthesia. As most
data in humans are obtained in the waking state, the value of the
current findings as a model for human LF rTMS is compromised.
The anesthetized state and specific choice of anesthetic likely affect
mechanisms of synaptic plasticity as suggested by rodent rTMS
results published by Gersner et al. [55]and discussed by Benali
et al. [37], and limit extension of the present findings to human
rTMS. Along these lines, we cautiously anticipate that the
establishment of LTD-like motor depression in rats will enable
our lab and others to test the effects of specific anesthetics on
rTMS plasticity mechanisms in rodents, in vivo. While the
magnitude direction and duration of MEP change after LF-rTMS
in rats, as well as its frequency and NMDAR dependence, suggest
some mechanistic overlap with human LF rTMS physiology,
further experiments to validate these early results, perhaps by ex
vivo tissue analysis that follows stimulation of unanesthetized
rodents will be needed [38,58].
Another pharmacologic confound of our experiment, also
common to human rTMS studies, is the systemic administration
of NMDAR antagonists. While we cautiously infer that the
NMDAR dependence of the LTD-like motor phenomenon is
cortical, we recognize that systemic drug treatment may affect the
corticomotor response at numerous sites between the cortex the
neuromuscular junction, as well as at cortical and subcortical
motor regulatory systems. Although beyond the scope of this
project, further delineation of the contribution of region-specific
neurotransmitter receptor populations to rTMS-related cerebral
plasticity, as can be accomplished by transgenic or optogenetic
methods, or by site-specific microinjections, will be helpful in
advancing the value of translational rTMS research [59–61].
Last, a necessary limitation of rodent rTMS research is the
reduction in TMS spatial resolution. The reduced focality of the
electromagnetic stimulus adds to the complexity of the interpre-
tation of TMS effects on distinct neuronal populations that has
been discussed in prior translational rTMS studies [37]. Here, as
in our prior work, we addressed the problem by eccentric
positioning of the coil center relative to the rat’s scalp midline,
such that the major coil conductive components are non-
tangential to the scalp and thus produce poor electromagnetic
coupling between the rat brain and the coil [19,20,62,63]. With
this setup, we note that the brachioradialis response was strongly
lateralized. However, we recognize that physiologic markers of
cortical activation outside the motor areas are absent in our
results, and thus interpretation of MEP modulation as resultant
from selective motor cortex stimulation should be with caution.
Conclusion
We provide the first in-vivo electrophysiologic demonstration of
LTD-like modulation of motor cortex excitability by low
frequency rTMS in anesthetized rats. Consistent with human
data, we show effects that outlast stimulation, frequency-depen-
dent cortico-spinal plasticity, as well as a further demonstration of
LF rTMS NMDAR-dependence. While limitations of rodent
rTMS methods will be essential to address, we are hopeful that our
results will facilitate future mechanistic studies, at the cellular and
molecular level. Such work is already in progress and that can be
best completed in translational rTMS models [37,55]. We suggest
a concerted effort to standardize rTMS studies in animals, with
emphasis on specialized coil development. We believe the present
study most closely approximates human rTMS findings to this
point and expansion of this model will be valuable to uncovering
basic rTMS mechanisms as well as to the development of
therapeutic rTMS protocols.
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